Cite
HARVARD Citation
Barrett, J. et al. (2020). Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors provides no recurrence or survival benefit. Journal of surgical oncology. 121 (7), pp. 1067-1073. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Barrett, J. et al. (2020). Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors provides no recurrence or survival benefit. Journal of surgical oncology. 121 (7), pp. 1067-1073. [Online].